홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Sodium Hydroxide → Tert-butyl 5-(2,4-dichlorophenyl)-7-methyl-2-(3-methyl-1,2,4-oxadiazol-5-yl)imidazo[1,2-a]pyrimidine-6-carboxylate

HRID 1868475
인쇄

반응식

HRID 1868475 반응식
[C:1]([C:4]1[N:5]=[C:6]2[N:11]=[C:10]([CH3:12])[C:9]([C:13]([O:15][C:16]([CH3:19])([CH3:18])[CH3:17])=[O:14])=[C:8]([C:20]3[CH:25]=[CH:24][C:23]([Cl:26])=[CH:22][C:21]=3[Cl:27])[N:7]2[CH:28]=1)(=[O:3])[NH2:2].[CH3:29][C:30]([N:32](C)C)=O.CC(N(C)C)=O.NO.Cl.[OH-].[Na+]>C1(C)C=CC=CC=1.O1CCOCC1.CC(O)=O>[Cl:27][C:21]1[CH:22]=[C:23]([Cl:26])[CH:24]=[CH:25][C:20]=1[C:8]1[N:7]2[CH:28]=[C:4]([C:1]3[O:3][N:32]=[C:30]([CH3:29])[N:2]=3)[N:5]=[C:6]2[N:11]=[C:10]([CH3:12])[C:9]=1[C:13]([O:15][C:16]([CH3:19])([CH3:18])[CH3:17])=[O:14]
참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트

참가 물질

8

반응물 4

HCID 14798Sodium HydroxideHCID 443297Hydroxyamine hydrochlorideHCID 19097097DMA dimethylacetamideHCID 57982465Tert-butyl 2-carbamoyl-5-(2,4-dichlorophenyl)-7-methylimidazo[1,2-a]pyrimidine-6-carboxylate

생성물 1

HCID 57982492Tert-butyl 5-(2,4-dichlorophenyl)-7-methyl-2-(3-methyl-1,2,4-oxadiazol-5-yl)imidazo[1,2-a]pyrimidine-6-carboxylate
수율 59%

시약·촉매·용매 3

HCID 176Acetic Acid용매HCID 1140Toluene용매HCID 312751,4-Dioxane용매

반응 조건

온도
90 °C

실험 절차

To a stirred solution of tert-butyl 2-carbamoyl-5-(2,4-dichlorophenyl)-7-methylimidazo[1,2-a]pyrimidine-6-carboxylate (60 mg, 0.14 mmol) in PhCH3 (3 mL) was added DMA-DMA (70 μL, 0.43 mmol). The reaction was heated to 90° C. for 2 h and was concentrated to afford the crude ester as a black oil. This crude product was dissolved in dioxane (2 mL) and AcOH (2 mL) and NH2OH.HCl (15 mg, 0.21 mmol) was added followed by NaOH (2N solution, 0.1 mL, 0.2 mmol). After heating to 90° C. for 2 h, the reaction was concentrated under reduced pressure and diluted with EtOAc. The organic layer was washed with H2O and brine prior to drying over anhydrous MgSO4. Filtration, concentration under reduced pressure and purification by silica gel chromatography afforded tert-butyl 5-(2,4-dichlorophenyl)-7-methyl-2-(3-methyl-1,2,4-oxadiazol-5-yl)imidazo[1,2-a]pyrimidine-6-carboxylate (38 mg, 58%) as a yellow solid.

후처리

  1. concentrationwas concentrated
  2. customto afford the crude ester as a black oil
  3. temperatureAfter heating to 90° C. for 2 h
  4. concentrationthe reaction was concentrated under reduced pressure
  5. additiondiluted with EtOAc
  6. washThe organic layer was washed with H2O and brine
  7. dry with materialto drying over anhydrous MgSO4
  8. filtrationFiltration, concentration
  9. customunder reduced pressure and purification by silica gel chromatography

출처 및 근거

ORD 기록
ord-a908db72e12543cb96282f489a72b1e2
출처 데이터셋
uspto-grants-2009_12
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US07635699B2

반응 노트

이 페이지에서참가 물질반응 조건실험 절차후처리출처 및 근거반응 노트